Mankind Pharma receives reaffirmation in credit rating from CRISIL

Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under:

Commercial paper (Rs 5,000 crore) - CRISIL A1+
Non convertible debentures (Rs 4,600 crore) - CRISIL AA+/ Stable
Non convertible debentures (Rs 400 crore) - CRISIL AA+/ Stable
Total bank loan facilities rated (Rs 1,250 crore) - CRISIL AA+/ Stable

Powered by Capital Market - Live News